INSIDER · CIK 1950499
Blume-Jensen Peter
President and CEO, Director at Acrivon Therapeutics, Inc. (ACRV)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$34KSold on the market
1Companies
Aug 27, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 202616:14 | Aug 25, 2026 | ACRVAcrivon Therapeutics, Inc. | President and CEO, Director | S · Sell | $2.21 | −14,036 | 2,230,052 | -1% | −$31K | ||
| Aug 20, 202616:07 | Aug 18, 2026 | ACRVAcrivon Therapeutics, Inc. | President and CEO, Director | S · Sell | $2.01 | −1,713 | 2,244,088 | -0% | −$3K |